Global Life Sciences, a California based Direct Sales Company, announced today, their plans to launch their new Industrial Hemp CBD Formulation into the US market. Cannabidiol (CBD) derived from Hemp is widely becoming accepted as an alternative to CBD extracted from other cannabis sources. Global Life Sciences' state of the art all natural water-soluble formulation of cannabidiol (CBD) is derived from the highest quality hemp. —
If you search “Hemp CBD” on the Internet, you won’t have any trouble finding volumes of information about Hemp CBD (Cannabidiol). There are numerous Labs, Universities, and even companies with commercial interest in CBD who are funding medical research into uncovering the health properties and benefits of CBD. Previously, the primary focus on CBD was in CBD derived from Marijuana, which due to the many legal, and moral issues associated with Marijuana, created many obstacles for researchers and those seeking to market CBD products. However, with the recent loosening of laws, and the introduction of The US Industrial Hemp Farming Act, there is now a great deal of focus on CBD derived from (legal) Industrial Hemp.
Global Life Sciences plans to begin its US distribution on September 19th, 2016 and is anticipating vigorous sales of its flagship product called “Tune”. Tune, a blend of High-Quality Hops, Turmeric and CBD oil (from industrial Hemp). Created by Global Life Sciences’, CEO and Cofounder, Eric H. Kuhrts, “Tune” is a water–soluble CBD formulation that is typically consumed by adding a few drops to a glass of juice or water. While Global Life Sciences doesn’t make any health claims about its product, most people who have tried “Tune” report feeling more alert, calmer and an overall sense of well-being, and usually all within minutes of consuming the product. According to Kuhrts, the product also has an accumulative effect.
Global Life Sciences opted for Direct Selling as their distribution method for their products. Growing in popularity, as well as respectability, Direct Selling is rapidly becoming a preferred choice for companies to get their products to Global Markets. The company has assembled a highly-experienced Executive Team, made up of individuals who are well-versed in the direct sales, marketing and distribution.
More About "Tune" Distribution
More about Eric H. Kuhrts:
In addition to being Global Life Sciences’ CEO, Co-Founder and Product Creator, Eric Kuhrts has an extensive background in the pharmaceutical and nutraceutical industries. Kuhrts is also the founder and President of numerous pharmaceutical, nutraceutical, and diagnostic companies, and is the inventor of numerous patents and innovative product technologies. He has been involved in all aspects of management and research related to pharmaceuticals, diagnostics, and consumer products for over 25 years, and raised millions of dollars for bio-pharmaceutical ventures. One of Kuhrts products generated over $180 million dollars in annual revenue, with cumulative sales of over $2 billion over a 10 year period, making it one of the biggest selling products in the dietary supplement industry. Currently, he has over 81 patents listed in the worldwide database of patents, the World Intellectual Property Organization. Kuhrts also developed and licensed a new drug formulation currently entering the phase III final phase of drug development as a cardiovascular drug, by a major biotech company that raised over $100 million dollars in new venture financing from a prestigious group of international finance companies to fund the development and approval of the drug in the US.
Name: Eric Grant
Email: Send Email
Phone: +1 206.227.7821
Release ID: 132084